Leerink Partnrs Has Pessimistic View of VKTX FY2029 Earnings
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at Leerink Partnrs dropped their FY2029 earnings estimates for shares of Viking Therapeutics in a report issued on Wednesday, April 23rd. Leerink Partnrs analyst T. Smith now expects that the biotechnology company will post earnings per share of $5.20 for the year, down from their previous […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at Leerink Partnrs dropped their FY2029 earnings estimates for shares of Viking Therapeutics in a report issued on Wednesday, April 23rd. Leerink Partnrs analyst T. Smith now expects that the biotechnology company will post earnings per share of $5.20 for the year, down from their previous […]
